2021-04-08T19:18:06-05:00 2020-05-31 BDO USA LLP 6100 ELTON AVE SUITE 1000 LAS VEGAS NV 89107 990 2019-06-01 880189404 NEVADA CANCER RESEARCH FOUNDATION INC % SHANNON YULE NEVA 7023840013 1750 E DESERT INN ROAD Suite STE LAS VEGAS NV 89169 SHANNON YULE PROGRAM COORDINATOR 7023840013 2021-04-08 true DAVID PORTER P00995237 7023841120 2019 2022-09-23 18:48:47Z X SHANNON YULE 1750 E DESERT INN ROADSTE 200 LAS VEGAS NV 89169 1379866 false X SNCRF.ORG X 1983 NV CANCER RESEARCH 3 2 19 4 0 1093628 1102525 176793 276348 1442 993 0 0 1271863 1379866 0 0 0 0 933983 994489 0 0 0 334228 441165 1268211 1435654 3652 -55788 303363 284678 68724 105827 234639 178851 CANCER RESEARCH false false 845973 COOPERATIVE GROUP ONCOLOGY TRIALS. PATIENTS WERE TREATED IN CORRELATION WITH VARIOUS RESEARCH PROGRAMS WITH FOLLOW-UP AND SUBMISSION OF DATA ON 603 PATIENTS. 211956 276348 INDUSTRY SPONSOR TRIALS. 47 PATIENTS ARE TREATED USING VARIOUS CANCER RELATED PHARMACEUTICALS WITH FOLLOW-UP AND SUBMISSION OF DATA. 1057929 true true false false false false false false false false true false false false true false true false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false true X 4 0 true 19 true false false false false false false false false false false false false false false false X 3 2 false false false false false false false true true false false true true true true true true true true false X SHANNON YULE 7023840013 1750 E DESERT INN ROAD STE 200 LAS VEGAS NV 89169 SHANNON YULE PROGRAM COORDINATOR 40.0 0.0 X 86893 0 0 JOHN ELLERTON MD PRESIDENT/TREASURER 5.0 0.0 X 30000 0 0 BRUCE BORGELT MD DIRECTOR 0.0 0.0 X 0 0 0 JIM CHRISTENSEN MD SECRETARY 0.0 0.0 X 0 0 0 116893 0 0 0 false false false NA NONE 0 X 1094343 8182 1102525 REIMBURSEMENTS 541700 123821 PHARMACEUTICALS 541700 152527 276348 993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1379866 X 0 0 0 0 116893 86893 30000 0 673778 539828 133950 0 158686 49955 108731 45132 37411 7721 0 0 15500 10447 5053 0 0 0 283700 260020 23680 0 0 14438 9731 4707 0 0 66088 52717 13371 18189 5369 12820 0 5131 3458 1673 12214 12214 0 22791 22791 3114 2100 1014 1435654 1057929 377725 0 30356 35254 191359 136295 0 0 0 0 0 0 2499 2499 0 0 0 0 0 0 274529 163899 79149 110630 0 0 0 0 0 0 0 0 0 0 303363 284678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 68724 105827 68724 105827 X 234639 178851 0 0 234639 178851 303363 284678 -55788 X false true X true true true X 781923 742280 918909 1093628 1102185 4638925 658654 644557 173820 176793 276348 1930172 0 0 0 1440577 1386837 1092729 1270421 1378533 6569097 0 0 0 6569097 69 82 129 1442 993 2715 0 69 82 129 1442 993 2715 0 10374 10374 1440646 1386919 1103232 1271863 1379526 6582186 0.99801 0.99993 0.00041 0.00007 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false 7373 6711 662 266132 156164 109968 1025 1025 110630 0 CAPITAL LEASE OBLIGATIONS 105827 105827 1641643 177900 83877 261777 1379866 1379866 1625303 177900 11749 189649 1435654 1435654 FORM 990, SCHEDULE D, PART XII, LINE 2D 2018 ACCOUNTS PAYABLE 36,956 2018 PAYROLL TAXES PAYABLE 6,374 2018 ACCRUED PAYROLL 30,320 2018 ACCRUED VACATION 17,870 2018 PREPAID EXPENSES -20,938 2019 ACCOUNTS PAYABLE -28,310 2019 PAYROLL TAXES PAYABLE -35,705 2019 ACCRUED VACATION -32,496 2019 PREPAID EXPENSES 14,180 --------- -11,749 FORM 990, SCHEDULE D, PART XI, LINE 2D 2018 ACCOUNTS RECEIVABLE 4,475 2018 RESEARCH RECEIVABLE 3,573 2018 GRANT RECEIVABLE 87,893 2018 PHARM RECEIVABLE 138,333 2018 ACCOUNTS REC-CCDR 53,975 2019 GRANT RECEIVABLE -141,682 2019 PHARM RECEIVABLE -171,929 2019 ACCOUNTS REC-CCDR -58,515 -------- -83,877 JOHN ELLERTON OFFICER EXPENSES X 2499 2499 false true false 2499 FORM 990, PART VI, SECTION B, LINE 11A THE PROGRAM ADMINISTRATOR, PROGRAM COORDINATOR, AND THE PRINCIPAL INVESTIGATOR WILL REVIEW FORM 990 AND DISCUSS WITH EACH OTHER ANY QUESTIONS AND/OR COMMENTS. THE PROGRAM ADMINISTRATOR WILL DIRECT THESE QUESTIONS TO THE TAX PREPARERS AND RELAY THE ANSWERS TO THE PROGRAM COORDINATOR AND PRINCIPAL INVESTIGATOR AND DETERMINE IF THEY ARE SATISFIED WITH THE RESPONSE AND NO FURTHER ACTION WILL BE REQUIRED. IF THEY ARE NOT SATISFIED, THEN A MEETING WILL BE SCHEDULED TO DISCUSS THE ISSUES WITH THE TAX RETURN PREPARERS. FORM 990, PART VI, SECTION B, LINE 12c ALL INVESTIGATORS WHO PARTICIPATE IN CLINICAL TRIALS ARE REQUIRED TO COMPLETE A FORM FDA 1572 ANNUALLY AND SUBMIT IT TO THE FOOD AND DRUG ADMINISTRATION. THE FORM FDA FORM 1572 IS A STATEMENT OF INVESTIGATOR (TITLE 21, CODE OF FEDERAL REGULATIONS (CFR) PART 312). IT INCLUDES A SUBPART, FINANCIAL DISCLOSURE FORM, WHICH THE INVESTIGATOR MUST ALSO COMPLETE ANNUALLY. IN ADDITION TO COMPLETING THE FORM FDA 1572, INVESTIGATOR AND FOUNDATION STAFF MUST ALSO COMPLETE AN ANNUAL FINANCIAL CONFLICT OF INTEREST DISCLOSURE FORM. THE POLICY AND PROCEDURES FOLLOWED BY THE FOUNDATION ARE INTENDED TO MEET THE MOST RECENT REQUIREMENTS PUBLISHED BY THE FEDERAL GOVERNMENT REGARDING REVISED FINANCIAL CONFLICT OF INTEREST (FCOI) REGULATION, PROMOTING OBJECTIVITY IN RESEARCH ON AUGUST 25, 2011 (42 CFR PART 50 SUBPART F AND 45 CFT PART 94). THE FOUNDATION WILL REPORT SIGNIFICANT FINANCIAL CONFLICTS OF INTEREST AS OUTLINED IN THE FEDERAL REGULATIONS. FORM 990, PART VI, SECTION B, LINE 15 THE FOUNDATION USES DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS AT SIMILAR ORGANIZATIONS. FOUNDATION EMPLOYEES ARE EVALUATED ANNUALLY AND THE RATE OF PAY IS DISCUSSED DURING THE EVALUATION AND IS WRITTEN AS PART OF THE EVALUATION PROCESS. THESE ARE THE RECORDS WITH RESPECT TO THE DECISIONS REGARDING THE COMPENSATION PROCESS. THE PRINCIPAL INVESTIGATOR IS COMPENSATED PER FEDERAL GUIDELINES. NONE OF THE OTHER TRUSTEES RECEIVE COMPENSATION. FORM 990, PART V, LINE 3b NEVADA CANCER RESEARCH FOUNDATION, INC DOES NOT CONDUCT A REGULARLY CARRIED ON UNRELATED TRADE OR BUSINESS WHICH IS NOT SUBSTANTIALLY RELATED TO THE PERFORMANCE BY THE ORGANIZATION OF ITS EXEMPT PURPOSES. FORM 990, PART VI, SECTION C, LINE 19 IF AN INQUIRY IS MADE, THEN THE PROGRAM ADMINISTRATOR, AFTER CONSULTATION WITH THE PRINCIPAL INVESTIGATOR, RESPONDS. FORM 990, PART V, LINE 14B FOUNDATION DOES NOT OFFER TANNING SERVICES AND RECEIVED NO PAYMENTS FOR TANNING SERVICES DURING THE FISCAL YEAR. FORM 990, PART VIII LINE 3 - INVESTMENT INCOME INTEREST INCOME 993 FORM 990 PART IX LINE 11G DESCRIPTION:DUES AND SUBSCRIPTIONS TOTAL FEES:24020 FORM 990 PART IX LINE 11G DESCRIPTION:LAB FEES TOTAL FEES:16984 FORM 990 PART IX LINE 11G DESCRIPTION:OUTSIDE SERVICES TOTAL FEES:134184 FORM 990 PART IX LINE 11G DESCRIPTION:POSTAGE TOTAL FEES:4597 FORM 990 PART IX LINE 11G DESCRIPTION:SERVICE CHARGES TOTAL FEES:156 FORM 990 PART IX LINE 11G DESCRIPTION:EQUIPMENT RENTAL TOTAL FEES:7043 FORM 990 PART IX LINE 11G DESCRIPTION:MILEAGE TOTAL FEES:8647 FORM 990 PART IX LINE 11G DESCRIPTION:TELEPHONE AND UTILITIES TOTAL FEES:14526 FORM 990 PART IX LINE 11G DESCRIPTION:OTHER EXPENSES TOTAL FEES:73543